SINGAPORE (May 11): Cordlife Group reported its fourth straight quarterly earnings as higher revenue from key markets and contributions from a newly-acquired subsidiary lifted profit from operations.
The pioneer in Asia’s private cord blood banking industry reported earnings of S$0.8 million in 3Q18, turning around from a net loss of S$0.4 million in 3Q17.
Revenue for the current quarter came in at S$17.7 million, 24.5% higher than S$14.2 million, mainly contributed by India and Singapore as well as the inclusion of the group’s newly acquired subsidiary, Healthbaby Biotech (Hong Kong) Co... (Click here to read the full story)